Inhaltsbereich
| 127 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
 Druckansicht
|
| Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor? |
| Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C |
| OncoTargets and therapy. 2015 Jul 23. doi: 10.2147/OTT.S78254. pii: ott-8-1843. pmc: PMC4516182 |
| PMID: 26229492 |
| Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice. |
| Pathria P, Gotthardt D, Prchal-Murphy M, Putz EM, Holcmann M, Schlederer M, Grabner B, Crncec I, Svinka J, Musteanu M, Hoffmann T, Filipits M, Berger W, Poli V, Kenner L, Bilban M, Casanova E, Müller M, Strobl B, Bayer E, Mohr T, Sexl V, Eferl R |
| Oncoimmunology. 2015 Jan 22. doi: 10.1080/2162402X.2014.998529. pii: 998529. pmc: PMC4485776 |
| PMID: 26137415 |
| Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype. |
| Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 1. pii: mdv215. doi: 10.1093/annonc/mdv215 |
| PMID: 25935792 |
| EVI1 promotes tumor growth via transcriptional repression of MS4A3. |
| Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B, Topakian T, Klingenbrunner S, Ziegler B, Spittler A, Zöchbauer-Müller S, Berger W, Wieser R |
| Journal of hematology & oncology. 2015 Mar 21. doi: 10.1186/s13045-015-0124-6. pii: 10.1186/s13045-015-0124-6. pmc: PMC4389965 |
| PMID: 25886616 |
| The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. |
| Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M |
| British journal of cancer. 2015 Mar 24. pii: bjc201598. doi: 10.1038/bjc.2015.98. pmc: PMC4402462 |
| PMID: 25867274 |
| Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study. |
| Ghanim B, Klikovits T, Hoda MA, Lang G, Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M, Filipits M, Scheed A, Jakopovic M, Samarzija M, Brcic L, Stancic-Rokotov D, Kern I, Rozman A, Dekan G, Klepetko W, Berger W, Glasz T, Dome B, Hegedus B |
| British journal of cancer. 2015 Jan 29. pii: bjc20159. doi: 10.1038/bjc.2015.9. pmc: PMC4453963 |
| PMID: 25633038 |
| Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer. |
| Russmueller G, Moser D, Würger T, Wrba F, Christopoulos P, Kostakis G, Seemann R, Stadler V, Wimmer G, Kornek G, Psyrri A, Filipits M, Perisanidis C |
| Oral oncology. 2014 Dec 17. pii: S1368-8375(14)00349-2. doi: 10.1016/j.oraloncology.2014.11.010 |
| PMID: 25532817 |
| Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. |
| Berghoff AS, Kiesel B, Widhalm G, Rajky O, Ricken G, Wöhrer A, Dieckmann K, Filipits M, Brandstetter A, Weller M, Kurscheid S, Hegi ME, Zielinski CC, Marosi C, Hainfellner JA, Preusser M, Wick W |
| Neuro-oncology. 2014 Oct 29. pii: nou307. doi: 10.1093/neuonc/nou307. pmc: PMC4490866 |
| PMID: 25355681 |
| Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score. |
| Sestak I, Cuzick J, Dowsett M, Lopez-Knowles E, Filipits M, Dubsky P, Cowens JW, Ferree S, Schaper C, Fesl C, Gnant M |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Oct 20. pii: JCO.2014.55.6894. doi: 10.1200/JCO.2014.55.6894 |
| PMID: 25332252 |
| Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells. |
| Veigel D, Wagner R, Stübiger G, Wuczkowski M, Filipits M, Horvat R, Benhamú B, López-Rodríguez ML, Leisser A, Valent P, Grusch M, Hegardt FG, García J, Serra D, Auersperg N, Colomer R, Grunt TW |
| International journal of cancer. Journal international du cancer. 2014 Nov 3. doi: 10.1002/ijc.29261 |
| PMID: 25302649 |
| Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. |
| Patton S, Normanno N, Blackhall F, Murray S, Kerr KM, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R, Thunnissen E |
| British journal of cancer. 2014 Jul 1. pii: bjc2014353. doi: 10.1038/bjc.2014.353. pmc: PMC4102953 |
| PMID: 24983368 |
| Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial? |
| Knauer M, Filipits M, Dubsky P |
| Breast care (Basel, Switzerland). 2014 Jun 19. doi: 10.1159/000362482. pii: brc-0009-0097. pmc: PMC4038313 |
| PMID: 24944551 |
| Low protein expression of MET in ER-positive and HER2-positive breast cancer. |
| Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M |
| Anticancer research. 2014 Mar 5. pii: 34/3/1227 |
| PMID: 24596364 |
| The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. |
| Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Feb 11. pii: 1078-0432.CCR-13-1845. doi: 10.1158/1078-0432.CCR-13-1845 |
| PMID: 24520097 |
| Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer. |
| Ma X, Rousseau V, Sun H, Lantuejoul S, Filipits M, Pirker R, Popper H, Mendiboure J, Vataire AL, Le Chevalier T, Soria JC, Brambilla E, Dunant A, Hainaut P |
| Molecular oncology. 2014 Jan 15. pii: S1574-7891(13)00187-7. doi: 10.1016/j.molonc.2013.12.015 |
| PMID: 24495481 |
| New developments in the treatment of squamous cell lung cancer. |
| Filipits M |
| Current opinion in oncology. 2014 Feb 6. doi: 10.1097/CCO.0000000000000049 |
| PMID: 24441504 |
| Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma. |
| Ghanim B, Hoda MA, Klikovits T, Winter MP, Alimohammadi A, Grusch M, Dome B, Arns M, Schenk P, Jakopovic M, Samarzija M, Brcic L, Filipits M, Laszlo V, Klepetko W, Berger W, Hegedus B |
| British journal of cancer. 2014 Jan 16. pii: bjc2013815. doi: 10.1038/bjc.2013.815. pmc: PMC3929892 |
| PMID: 24434429 |
| Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma. |
| Preusser M, Berghoff AS, Manzl C, Filipits M, Weinhäusel A, Pulverer W, Dieckmann K, Widhalm G, Wöhrer A, Knosp E, Marosi C, Hainfellner JA |
| Clinical neuropathology. 2013 Dec 23. pii: 11145. pmc: PMC3891253 |
| PMID: 24359605 |
| Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. |
| Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt494. doi: 10.1093/annonc/mdt494 |
| PMID: 24347518 |
| Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. |
| Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N |
| Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2013 Dec 6. pii: modpathol2013204. doi: 10.1038/modpathol.2013.204 |
| PMID: 24309322 |
| 127 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
